Literature DB >> 8221694

Microvascular mechanisms of change in tumor blood flow due to angiotensin II, epinephrine, and methoxamine: a functional morphometric study.

K Hori1, Q H Zhang, S Saito, S Tanda, H C Li, M Suzuki.   

Abstract

To elucidate the microvascular mechanisms of change in tumor blood flow elicited by vasopressors, a functional morphometric study of the s.c. microcirculation within a rat transparent chamber was performed. Arteriolar vessels were classified centripetally (a2-a5) according to Strahler's method. Arteriolar pressure in each segment both under normotension and under hypertension induced by angiotensin II, epinephrine, or methoxamine was measured using a microocclusion technique. Vasoconstriction was estimated by changes in vessel diameters. In addition, tissue blood flow of the subcutis and s.c. tumor (LY80, a variant of Yoshida sarcoma) under the same conditions was measured with the hydrogen clearance method. By comparing the sites of the greatest pressure drop and the vasoconstriction induced by each vasopressor, we assessed the sites of vascular resistance (VR) which showed increases due to these vasopressors. The greatest VR increase elicited by angiotensin II occurred across a2 vessels. On the other hand, the sites of VR increase due to epinephrine were in a3 vessels and larger vessels upstream from a3 arterioles. The VR increase induced by methoxamine was much smaller than that induced by epinephrine. We conclude that the fact that the sites of increased VR differ with each vasopressor is the primary reason that various vasopressors have been found to produce different changes in tumor blood flow.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8221694

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Semiquantitative imaging measurement of baseline and vasomodulated normal prostatic blood flow using sildenafil.

Authors:  J R Haaga; A Exner; B Fei; A Seftel
Journal:  Int J Impot Res       Date:  2006-05-25       Impact factor: 2.896

2.  Enhancement of fluid filtration across tumor vessels: implication for delivery of macromolecules.

Authors:  P A Netti; L M Hamberg; J W Babich; D Kierstead; W Graham; G J Hunter; G L Wolf; A Fischman; Y Boucher; R K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

Review 3.  Drug delivery and transport to solid tumors.

Authors:  Seong Hoon Jang; M Guillaume Wientjes; Dan Lu; Jessie L S Au
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200

4.  Vasomodulation of tumor blood flow: effect on perfusion and thermal ablation size.

Authors:  Hanping Wu; Agata A Exner; Tianyi M Krupka; Brent D Weinberg; John R Haaga
Journal:  Ann Biomed Eng       Date:  2008-12-16       Impact factor: 3.934

5.  Angiotensin II (AII) induced hypertension chemotherapy (IHC) for unresectable gastric cancer: with reference to resection after down staging.

Authors:  H Sato; K Sugiyama; M Hoshi; M Urushiyama; K Ishizuka
Journal:  World J Surg       Date:  1995 Nov-Dec       Impact factor: 3.352

6.  A novel immunoscintigraphy technique using metabolizable linker with angiotensin II treatment.

Authors:  Y Nakamoto; H Sakahara; T Saga; N Sato; S Zhao; Y Arano; Y Fujioka; H Saji; J Konishi
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

7.  Disparate responses of tumour vessels to angiotensin II: tumour volume-dependent effects on perfusion and oxygenation.

Authors:  O Thews; D K Kelleher; P Vaupel
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

8.  Variation of growth rate of a rat tumour during a light-dark cycle: correlation with circadian fluctuations in tumour blood flow.

Authors:  K Hori; Q H Zhang; H C Li; S Saito
Journal:  Br J Cancer       Date:  1995-06       Impact factor: 7.640

9.  The response of tumour vasculature to angiotensin II revealed by its systemic and local administration to 'tissue-isolated' tumours.

Authors:  G M Tozer; K M Shaffi
Journal:  Br J Cancer       Date:  1995-09       Impact factor: 7.640

10.  Induction of tumour blood flow stasis and necrosis: a new function for epinephrine similar to that of combretastatin A-4 derivative AVE8062 (AC7700).

Authors:  K Hori; S Saito
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.